Revenio is a global leader in ophthalmic diagnostics and ophthalmic devices. The Revenio Group's eye diagnostic solutions under the iCare brand include intraocular pressure measuring devices, fundus imaging devices and perimeters. The main tools for identifying, diagnosing and monitoring glaucoma during treatment are intraocular pressure measurement (tonometry), fundus imaging and visual field examination (perimetry).
Key figures
Year 2021e 2022e 2023e 2024e
growth% 27.3% 25.5% 23.8% 23.1%
EBIT-% 28.1% 31.4% 34.3% 35.0%
Dividend% 0.9% 1.2% 1.4% 2.0%
ROI-% 23% 30% 35% 37%
(prediction figures from inderes.fi, not mine)
Increased my position by 25%. Still fundamentally strong.
Key figures
Year 2021e 2022e 2023e 2024e
growth% 27.3% 25.5% 23.8% 23.1%
EBIT-% 28.1% 31.4% 34.3% 35.0%
Dividend% 0.9% 1.2% 1.4% 2.0%
ROI-% 23% 30% 35% 37%
(prediction figures from inderes.fi, not mine)
Increased my position by 25%. Still fundamentally strong.
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。